Nefopam is a clinically effective analgesic agent used to control mild to moderate pain, whose mechanism of action is unknown. We have investigated the antinociceptive activity of nefopam in the mouse abdominal constriction assay and tail immersion test (48°C). Nefopam was found to possess a high degree of potency against acetic acid-induced visceral nociception (ED50 2.5 mg kg−1). In the presence of the opioid receptor antagonists, naloxone or naltrindole, the resulting nefopam dose–response relationships were shifted to the right. Naloxone or naltrindole had no effect upon aspirin (ED50 32.1 mg kg−1) or clonidine (ED50 0.061 mg kg−1) induced antinociception. Acetorphan (10 mg kg−1; s.c.), an inhibitor of neutral endopeptidase (EC 3.4.24.1...